Csf2-KO
Nomenclature
C57BL/6JSmo-Csf2em2Smoc
Cat. NO.
NM-KO-190532
Strain State
Embryo cryopreservation
Gene Summary
Gene Symbol
CSF2
Model Description
Validation Data

Fig.1 Detection of Csf2 expression in lung by RT-PCR. Lung RNA was extracted from 7-year-old male wild-type C57BL/6 (WT) and homozygous Csf2-KO mice (HO) (n=3), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mRNA primers. Mouse Gapdh mRNA (123 bp) was detectable both in wild-type C57BL/6 mice and homozygous Csf2-KO mice. Mouse Csf2 mRNA (146 bp/138 bp) was detectable only in wild-type mice but not in homozygous Csf2-KO mice.
Abbr. M, marker; HO, homozygous; WT, wild type.

Fig.2 Detection of Csf2 expression in lung by qPCR. Lung RNA were extracted from 7-year-old male wild-type C57BL/6 (WT) and homozygous Csf2-KO mice (HO) (n=3), then cDNA libraries were synthesized by reverse transcription, followed by qPCR with mouse Csf2 and mouse Gapdh primers. Relative expression represents the mouse Csf2 mRNA level relative to its average expression in homozygous Csf2-KO mice. Mouse Csf2 mRNA was detectable only in wild-type mice but not in homozygous Csf2-KO mice.
Abbr. M, marker; HO, homozygous; WT, wild type.

Fig.3 Detection of mouse CSF2 expression in serum of WT C57BL/6 mice and HO CSF2-KO mice by ELISA. Serum were collected from wild-type C57BL/6 mice (n=3, male, 11 weeks old) and HO CSF2-KO mice (n=3, male, 11 weeks old), and analyzed by ELISA with anti-mCSF2 ELISA kit. Mouse CSF2 was exclusively detectable in wild-type C57BL/6 mice.
Abbr. HO, homozygous; WT, wild type.
Note. CSF2-KO and C57BL/6 mice were i.p. injected with LPS(5mg/kg) for 2h.
You may also like
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreWorkshop:Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn moreCustomizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more